Stanford scientists have developed CardioGuardian, a method that uses cell-free RNA from a routine blood draw to estimate an individual's inherited risk of cardiovascular disease, capturing heritable risk that conventional DNA-based approaches miss.
Stanford researchers have identified an appropriate method and dosage for radiotherapy-based noninvasive lung volume reduction to treat severe emphysema.